US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

28.11

+0.03740.13%

Post-market: 28.110.00000.00%16:15 EDT

Volume:278

Turnover:8K

Market Cap:1.41M

PE:- -

High:28.11

Open:28.07

Low:28.11

Close:28.07

52wk High:29.89

52wk Low:24.32

Shares:50.00K

Float Shares:50.00K

Volume Ratio:1.70

T/O Rate:0.56%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 4.89%

AbbVie Targets Jawline and Neck Aesthetics With New Botox and Juvéderm Study

AbbVie (ABBV) Lands Two FDA Breakthrough Tags For Temab A In Cancer

Simply Wall St.

Estée Lauder Appoints Gaétane Baudry SVP, Global General Manager of Bobbi Brown

GaÉTane Baudry Appointed Senior Vice President/Global General Manager, Bobbi Brown

THOMSON REUTERS

Align Technology Inc. Stock Outperforms Competitors Despite Losses on the Day

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Hims & Hers Names Jon Franklin as Chief Accounting Officer

THOMSON REUTERS

Hims & Hers Names Jonathan Franklin Principal Accounting Officer as Irene Becklund Resigns Role

NielsenIQ Names Puneet Sharma Managing Director for India

Micro-Cap Stock Veraxa Biotech is Down 96% This Year. Can Next-Gen Drug Testing Save It?

AbbVie’s telisotuzumab adizutecan gets two FDA Breakthrough Therapy Designations

AbbVie Says FDA Grants Breakthrough Therapy Status for ABBV-400 in Metastatic Colorectal Cancer

Abbvie's Telisotuzumab Adizutecan (Temab-A) Receives Two Breakthrough Therapy Designations from the U.S. FDA for Crc and Nsclc

THOMSON REUTERS

AbbVie's Epkinly Could Be Preferred Frontline DLBCL Agent, UBS Says

MT Newswires Live

European Shares Gain as Genmab Jumps, Bond Yields Retreat

LIVE Markets-a Health Boost for the STOXX

Genmab at 3-Year High After Blood Cancer Drug Combination Study Results

Align Technology Inc. Stock Underperforms Monday When Compared to Competitors

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/GLAM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":28.1075,"timestamp":1791489600000,"preClose":28.0701,"halted":0,"volume":278,"hourTrading":{"tag":"盘后","latestPrice":28.1075,"preClose":28.1075,"latestTime":"16:15 EDT","volume":8,"amount":224.86,"timestamp":1791490500331,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0013323785807674948,"floatShares":50000,"shares":50000,"eps":0,"marketStatus":"Post-Mkt","change":0.0374,"latestTime":"10-08 19:03:04 EDT","open":28.0701,"high":28.1075,"low":28.1075,"amount":7891,"amplitude":0,"askPrice":42.1,"askSize":200,"bidPrice":14.04,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791504000000},"marketStatusCode":4,"adr":0,"exchange":"CBOE","adjPreClose":28.0701,"nav":27.92,"aum":1396000,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":28.1075,"preClose":28.1075,"latestTime":"16:15 EDT","volume":8,"amount":224.86,"timestamp":1791490500331,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.701348,"impliedVol":0.0781,"impliedVolPercentile":0.0808},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":50000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.701348,"shares":50000,"dividePrice":0,"high":28.1075,"amplitude":0,"preClose":28.0701,"low":28.1075,"week52Low":24.3178,"pbRate":"--","week52High":29.89,"institutionHeld":0,"latestPrice":28.1075,"eps":0,"divideRate":0,"volume":278,"delay":0,"ttmEps":0,"open":28.0701,"prevYearClose":25.82,"prevWeekClose":27.6182,"prevMonthClose":27.766,"prevQuarterClose":27.766,"fiveDayClose":27.5282,"twentyDayClose":27.7464,"sixtyDayClose":27.8939},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674735007","title":"Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 4.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674735007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674735007?lang=en_us&edition=fundamental","pubTime":"2026-10-09 03:55","pubTimestamp":1791489310,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Hims and Hers Health (HIMS), with shares down $1.45 near $28.09. Options volume roughly in line with ave...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-hims-and-hers-health-with-shares-down-4-89-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-hims-and-hers-health-with-shares-down-4-89-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HEAL","HIMY","HMYY","HIMC","BK4196","GLAM","HIYY","HIMS","THNR","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674090490","title":"AbbVie Targets Jawline and Neck Aesthetics With New Botox and Juvéderm Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2674090490","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674090490?lang=en_us&edition=fundamental","pubTime":"2026-10-09 00:32","pubTimestamp":1791477126,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. This AbbVie study, officially titled “A Prospective, Open-label Study to Evalua...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-jawline-and-neck-aesthetics-with-new-botox-and-juvederm-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-jawline-and-neck-aesthetics-with-new-botox-and-juvederm-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1074936037.SGD","LU0289739343.SGD","SG9999015986.USD","MEDX","LU1732799900.SGD","LU1732800096.USD","LU0795875169.SGD","XLV","LU2347655073.USD","LU1551013425.SGD","IE000BZT7R73.USD","IXJ","IE00BBT3K403.USD","LU1037948541.HKD","JDOC","RXL","LU1929549753.HKD","LU1934455863.HKD","LU1923622614.USD","ABBV","LU0198837287.USD","LU0058720904.USD","LU1934455194.USD","VHT","LU1267930573.SGD","LU1934455277.USD","IE000MB6IJN5.SGD","LU2237443622.USD","GLAM","SG9999003800.SGD","LU0122379950.USD","IE00BLSP4239.USD","PJP","LU1093756325.SGD","LU0912757837.SGD","LU0882574055.USD","PPH","AGNG","FHLC","IE000F7OJYX1.SGD","LU0029864427.USD","IYH","LU1989772840.SGD","LU2129689605.HKD","IE00BGHQF631.EUR","LU1162221912.USD","FTXH","TRUH","LU1291159041.SGD","LU2089283258.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673067440","title":"AbbVie (ABBV) Lands Two FDA Breakthrough Tags For Temab A In Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673067440","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673067440?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:42","pubTimestamp":1791470551,"startTime":"0","endTime":"0","summary":"AbbVie (NYSE:ABBV) received two FDA Breakthrough Therapy Designations for telisotuzumab adizutecan, also known as Temab-A.\nThe designations cover treatment of colorectal cancer and non small cell lung cancer, both high unmet need tumor types.\nThese are the first Breakthrough Therapy Designations granted for Temab-A within AbbVie's growing antibody drug conjugate portfolio.\nThe twin FDA Breakthrough Therapy Designations for Temab-A in colorectal and lung cancer connect to a wider picture our...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-lands-two-fda-breakthrough-tags-for-temab-a-in-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-lands-two-fda-breakthrough-tags-for-temab-a-in-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FHLC","IE00B19Z3581.USD","BK4559","LU0859254822.USD","LU0708994859.HKD","VHT","LU0289961442.SGD","LU0965508806.USD","LU1061106388.HKD","LU2089984988.USD","PJP","LU1548497426.USD","LU0553294199.USD","LU1093756325.SGD","LU1934455277.USD","TRUH","XLV","LU2087621335.USD","AGNG","IE00B19Z3B42.SGD","LU2357627491.SGD","RXL","SG9999003800.SGD","LU2129689605.HKD","GLAM","LU1720051017.SGD","LU0985320562.USD","IXJ","LU2347655156.SGD","LU1074936037.SGD","BK4533","LU0124676726.USD","IE000MB6IJN5.SGD","LABU","LU0861579265.USD","LU0726765562.USD","JDOC","LU2089283258.USD","LU0310799852.SGD","LU1057294990.SGD","FTXH","IYH","MEDX","LU1244550494.USD","LU0689626769.HKD","ABBV","LU1093756168.USD","LU1983299246.USD","LU1162221912.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673074087","title":"Estée Lauder Appoints Gaétane Baudry SVP, Global General Manager of Bobbi Brown","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074087","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673074087?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:04","pubTimestamp":1791461087,"startTime":"0","endTime":"0","summary":"Estée Lauder appoints Gaétane Baudry SVP, global general manager of Bobbi BrownThe Estée Lauder Companies appointed Gaétane Baudry senior vice president, global general manager of Bobbi Brown, effecti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL4cYbGw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1988902786.USD","BK4588","LU2552382215.SGD","EL","LU2404859667.USD","BK4504","LU2552382132.HKD","BK4533","LU1064131342.USD","LU0690374615.EUR","BK4558","LU2264538146.SGD","BK4183","LU0690374961.EUR","GLAM","BK4548","LU2404859741.USD","LU2552382058.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673074438","title":"GaÉTane Baudry Appointed Senior Vice President/Global General Manager, Bobbi Brown","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074438","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673074438?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460809,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUA1BDV8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1988902786.USD","LU2264538146.SGD","GLAM","BK4183","LU2552382058.USD","LU2404859741.USD","BK4558","BK4588","BK4504","BK4585","EL","BK4533","LU1064131342.USD","BK4548","LU0690374961.EUR","LU0690374615.EUR","LU2552382215.SGD","LU2552382132.HKD","LU2404859667.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673438170","title":"Align Technology Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673438170","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673438170?lang=en_us&edition=fundamental","pubTime":"2026-10-08 05:16","pubTimestamp":1791407760,"startTime":"0","endTime":"0","summary":"DJ Align Technology Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Align Technology Inc.  slipped 1.12% to $139.87 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.22% to 7,801.77 and Dow Jones Industrial Average  falling 0.66% to 51,179.87.Align Technology Inc. closed 30.22% below its 52-week high of $200.44, which the company achieved on April 21st.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Zimmer Biomet Holdings Inc.  fell 1.33% to $88.49 and Dentsply Sirona Inc.  rose 0.23% to $8.54.Trading volume  remained 247,306 below its 50-day average volume of 926,130.Data source: Dow Jones Market Data, FactSet. Data compiled October 7, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","LU0130517989.USD","IE00B7SZLL34.SGD","LU0792757196.USD","LU2106854487.HKD","LU0889566641.SGD","LU0648001328.SGD","LU1267930813.SGD","LU2023250504.SGD","GLAM","LU0128525929.USD","LU0310799852.SGD","IE00B19Z3581.USD","LU0310800379.SGD","BK4585","BK4588","BK4504","ALGN","LU2023250843.SGD","LU0130102774.USD","IE00B19Z3B42.SGD","LU0477156953.USD","BK4534","LU0708994859.HKD","IE0002270589.USD","BK4566","ZBH","LU1917777945.USD","LU0980610538.SGD","LU1267930490.SGD","LU0006061336.USD","BK4198","LU0211328371.USD","LU0211327993.USD","XRAY","BK4082","LU1201861249.SGD","LU1267930573.SGD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673482090","title":"Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2673482090","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673482090?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:55","pubTimestamp":1791406500,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Underperforms Wednesday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  rose 1.17% to $94.45 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.22% to 7,801.77 and Dow Jones Industrial Average  falling 0.66% to 51,179.87.This was the stock's fourth consecutive day of gains.Estee Lauder Cos. Cl A closed 22.35% short of its 52-week high of $121.64, which the company reached on February 3rd.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  rose 1.44% to $258.45, Procter & Gamble Co.  fell 0.40% to $147.82, and Coty Inc. Cl A  rose 0.36% to $2.80.Trading volume  remained 899,709 below its 50-day average volume of 3.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 7, 2026","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRUH","FSTA","VHT","LU0683600562.USD","LU1988902786.USD","SG9999002224.SGD","LU0426412945.USD","LU2129689431.USD","UGE","TRUO","EL","IYH","LU0210528500.USD","SG9999014542.SGD","XLV","LU0057025933.USD","LU0096364046.USD","BK4550","FTXH","BK4534","BMED","FHLC","JDOC","LU1551013342.USD","LU0345770993.USD","LU1145028129.USD","LU0070217475.USD","LU0426417589.USD","JNJ","IHE","PG","LU2430703251.USD","PJP","GDOC","SG9999015341.SGD","XLP","LU2468319806.SGD","IE000MB6IJN5.SGD","LU1244550221.USD","LU1066051225.USD","IE000M9KFDE8.USD","LU1778281490.HKD","LU1074936037.SGD","COTY","SG9999015358.SGD","GLAM","RXL","MEDX","LU0795875086.SGD","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673010745","title":"Hims & Hers Names Jon Franklin as Chief Accounting Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673010745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673010745?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:17","pubTimestamp":1791404220,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUA3C1ZZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIYY","BK4196","HIMY","GLAM","THNR","HIMS","HIMZ","HEAL","HIMC","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673010249","title":"Hims & Hers Names Jonathan Franklin Principal Accounting Officer as Irene Becklund Resigns Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2673010249","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673010249?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:14","pubTimestamp":1791404067,"startTime":"0","endTime":"0","summary":"Hims & Hers names Jonathan Franklin principal accounting officer as Irene Becklund resigns roleHims & Hers Health appointed Jonathan M. Franklin as principal accounting officer effective Oct. 9, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL7sGjBK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HIMY","HMYY","HIMC","BK4196","GLAM","HIYY","HIMS","THNR","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673101379","title":"NielsenIQ Names Puneet Sharma Managing Director for India","url":"https://stock-news.laohu8.com/highlight/detail?id=2673101379","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673101379?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:19","pubTimestamp":1791379142,"startTime":"0","endTime":"0","summary":"NielsenIQ names Puneet Sharma managing director for IndiaNIQ Global Intelligence named Puneet Sharma managing director for India, effective Sept. 30, 2026, based in Mumbai.Sharma will run India commer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL34sLzC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4588","LU0128525929.USD","LU1267930573.SGD","NIQ","BK4585","GLAM","KVUE","LU0029864427.USD","LU0792757196.USD","RSPS","IE00BFXG1179.USD","LU1267930813.SGD","IE00B3T34201.USD","LU0889566641.SGD","LU0310800379.SGD","LU0708994859.HKD","BK4009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673013460","title":"Micro-Cap Stock Veraxa Biotech is Down 96% This Year. Can Next-Gen Drug Testing Save It?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673013460","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673013460?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:09","pubTimestamp":1791378540,"startTime":"0","endTime":"0","summary":"Since going public, Veraxa Biotech has endured a deep slump that has pushed its stock into single-digit territory. Its recovery may hinge on the adoption of new drug-testing protocols to accelerate it","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1923622614.USD","RXL","LU1934455194.USD","BK4581","LU0456855351.SGD","LU1720051017.SGD","LU0912757837.SGD","LU1839511570.USD","IE00B3PB1722.GBP","XBI","LU0949170772.SGD","AZNH","GLAM","LU0942090050.USD","LU1929549753.HKD","XLV","MEDX","VHT","IYH","FTXH","IE00B19Z3581.USD","IE00BLSP4452.SGD","LU0965509101.SGD","PPH","LU2089284900.SGD","LU1057294990.SGD","LU2456880835.USD","LU1162221912.USD","SG9999001440.SGD","LU1720051108.HKD","LU2237443465.HKD","VRXA","PJP","BK4534","LU0708994859.HKD","IE00BN8TJ469.HKD","TRUH","BK4566","ABBV","LU1829250122.USD","JDOC","LU2133065610.SGD","LU2125909247.SGD","FHLC","LU0122379950.USD","LU0198837287.USD","LU0114720955.EUR","AZN","IXJ","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018273","title":"AbbVie’s telisotuzumab adizutecan gets two FDA Breakthrough Therapy Designations","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018273","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018273?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:36","pubTimestamp":1791376566,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced that the U.S. FDA has granted two Breakthrough Therapy Designations for telisotuzumab adizutecan in colorectal cancer and n...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvies-telisotuzumab-adizutecan-gets-two-fda-breakthrough-therapy-designations-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvies-telisotuzumab-adizutecan-gets-two-fda-breakthrough-therapy-designations-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLAM","SG9999015986.USD","LU1670627923.USD","LU2089284900.SGD","BK4559","LU1551013425.SGD","XLV","LU0708994859.HKD","LABU","LU1989772923.USD","RXL","IE00BGHQF631.EUR","LU2237443549.SGD","IE00BLSP4239.USD","MEDX","PJP","LU1496350171.SGD","LU0689472784.USD","LU0417517546.SGD","FTXH","IE00B19Z3581.USD","LU0029864427.USD","SG9999015978.USD","LU0965508806.USD","FHLC","LU2112291526.USD","IE00BJT1NW94.SGD","AGNG","IE000F7OJYX1.SGD","LU1548497426.USD","JDOC","BK4581","LU1496350502.SGD","LU1989772840.SGD","VHT","LU1839511570.USD","SG9999003800.SGD","IE00BN8TJ469.HKD","PPH","IE0004445239.USD","LU0158827948.USD","TRUH","BK4550","IXJ","IYH","IE00B4R5TH58.HKD","LU0456855351.SGD","LU1093756325.SGD","ABBV","LU0738911758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018498","title":"AbbVie Says FDA Grants Breakthrough Therapy Status for ABBV-400 in Metastatic Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018498","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018498?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:32","pubTimestamp":1791376326,"startTime":"0","endTime":"0","summary":"AbbVie says FDA grants breakthrough therapy status for ABBV-400 in metastatic colorectal cancerAbbVie won two FDA Breakthrough Therapy Designations for telisotuzumab adizutecan, an investigational c-M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL6jsywg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","BK4559","LU1732799900.SGD","XLV","LU0965509283.SGD","LU1989772923.USD","IE00B42XCP33.USD","RXL","LU0256863811.USD","MEDX","PJP","SG9999015952.SGD","LU0289961442.SGD","LU1989771016.USD","IE000BZT7R73.USD","LU2237443465.HKD","LU0198837287.USD","FTXH","IE00BFTCPJ56.SGD","LU1003077747.HKD","FHLC","IE00BJT1NW94.SGD","LU1074936037.SGD","LU0661504455.SGD","LU0203347892.USD","AGNG","LU0122379950.USD","LU1923622614.USD","LU1548497426.USD","JDOC","LU0058720904.USD","BK4534","VHT","IE00BDGV0183.EUR","IE00BLSP4452.SGD","LU0965509101.SGD","IE00BN8TJ469.HKD","LU0795875086.SGD","PPH","LU1732800096.USD","LU2133065610.SGD","TRUH","BK4550","IXJ","IYH","IE00B2B36J28.USD","LU0124676726.USD","LU1093756325.SGD","LU2125909247.SGD","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018199","title":"Abbvie's Telisotuzumab Adizutecan (Temab-A) Receives Two Breakthrough Therapy Designations from the U.S. FDA for Crc and Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018199","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018199?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376206,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUA8YWCC0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGNG","LU0708994859.HKD","BK4550","LU0472753341.HKD","LU0456855351.SGD","PPH","LU1496350502.SGD","GLAM","LU1244550577.SGD","XLV","LU1244550221.USD","BK4581","LU1720051017.SGD","LU0234572021.USD","VHT","FTXH","TRUH","LU0912757837.SGD","LU1585245621.USD","IYH","LU0211327993.USD","LU0211328371.USD","LU1267930573.SGD","LU1718418525.SGD","MEDX","ABBV","LU1670627923.USD","LU2087621335.USD","IE00BLSP4239.USD","LU0417517546.SGD","SG9999015978.USD","FHLC","IXJ","IE00BDGV0183.EUR","LU1670628061.USD","PJP","LU0943347566.SGD","RXL","IE00B19Z3581.USD","JDOC","LU0949170772.SGD","LU0320765646.SGD","LU1037948541.HKD","LU1934455277.USD","LU0859254822.USD","LU1023059063.AUD","LU1236620750.USD","LU0170899867.USD","LU0029864427.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673050342","title":"AbbVie's Epkinly Could Be Preferred Frontline DLBCL Agent, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2673050342","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673050342?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:41","pubTimestamp":1791304881,"startTime":"0","endTime":"0","summary":"AbbVie's  Epkinly could become a preferred frontline option in diffuse large B-cell lymphoma, as its phase 3 result looks favorable against other recently positive regimens on a cross-trial basis, UBS Securities said.The investment firm said in a Monday note that the data would support use of Epkinly with R-CHOP chemotherapy, potentially ahead of combinations such as Roche's Polivy and glofitimab.UBS sees a potential multi-billion-dollar opportunity, versus consensus peak sales of just $1 billion to $2 billion for AbbVie, which splits economics with Genmab.The brokerage also noted the study succeeded in a broader patient population than expected, and said it still needs to see full data and safety, which could come at ASH in December.UBS has a neutral rating on AbbVie, with a $260 price target.Price: 267.95, Change: +2.19, Percent Change: +0.83","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0211328371.USD","LU2089984988.USD","LU0114720955.EUR","LU1496350171.SGD","LU0472753341.HKD","LU1074936037.SGD","LU0726765562.USD","SG9999011175.SGD","AGNG","LU0203345920.USD","MEDX","LU2237443382.USD","LU0198837287.USD","LU1551013425.SGD","IE0002141913.USD","LU0289739699.SGD","IXJ","ABBV","LU1061106388.HKD","GLAM","LU0069063385.USD","LU2237443465.HKD","JDOC","LU2433249047.HKD","LU1267930573.SGD","PPH","IE0002270589.USD","XLV","TRUH","PJP","BK4581","LU0029864427.USD","IE00BDGV0183.EUR","LU2237443895.HKD","SG9999015945.SGD","IYH","LU0456855351.SGD","RXL","SG9999015978.USD","IE00B3PB1722.GBP","FHLC","LU0310799852.SGD","LU0234572021.USD","LU1923622614.USD","LU1934455277.USD","LU0689626769.HKD","VHT","FTXH","LU0256863811.USD","LU1718418525.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673300037","title":"European Shares Gain as Genmab Jumps, Bond Yields Retreat","url":"https://stock-news.laohu8.com/highlight/detail?id=2673300037","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673300037?lang=en_us&edition=fundamental","pubTime":"2026-10-06 16:51","pubTimestamp":1791276686,"startTime":"0","endTime":"0","summary":"European shares gain as Genmab jumps, bond yields retreatOct 6 (Reuters)-European shares rose towards one-week highs on Tuesday, buoyed by gains in healthcare stocks after Genmab's upbeat drug-trial r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL4N45S0H3:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","FTXH","LU0661504455.SGD","LU0198837287.USD","XLV","LU2129689431.USD","IE00BGHQF631.EUR","LU1585245621.USD","LU2237443895.HKD","LU0203345920.USD","LU0472753341.HKD","LU1929549753.HKD","GLAM","LU0114720955.EUR","SG9999015945.SGD","LU1162221912.USD","FHLC","IE0002141913.USD","IE00B2B36J28.USD","LU0861579265.USD","LU1989771016.USD","IXJ","PJP","MEDX","IE00B3PB1722.GBP","VHT","PPH","BK4559","TRUH","LU1551013342.USD","LU0738911758.USD","LU1057294990.SGD","LU1061106388.HKD","LU2089984988.USD","LU1236620750.USD","LU1718418525.SGD","LU0234570918.USD","LU1496350171.SGD","LU2133065610.SGD","JDOC","RXL","SG9999001440.SGD","AGNG","LU1670627923.USD","LU2237443382.USD","LU0203347892.USD","BK4534","LU0965508806.USD","LU1732799900.SGD","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673079034","title":"LIVE Markets-a Health Boost for the STOXX","url":"https://stock-news.laohu8.com/highlight/detail?id=2673079034","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673079034?lang=en_us&edition=fundamental","pubTime":"2026-10-06 15:54","pubTimestamp":1791273288,"startTime":"0","endTime":"0","summary":"LIVE MARKETS-A health boost for the STOXXAdds blog postSTOXX 600 up 0.8%Healthcare stocks lead gains, boosted by 8% jump in Genmab sharesWall St futures steadyWelcome to the home for real-time coverag","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL6N45S0G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000WAW04H5.SGD","LU1162221912.USD","LU1551013425.SGD","LU0949170772.SGD","LU0395794307.EUR","SG9999015952.SGD","LU1093756325.SGD","LU0661504455.SGD","ABBV","LU0256863811.USD","PPH","RXL","SG9999001440.SGD","BK4139","LU0211327993.USD","LU0128525929.USD","LU2129689514.USD","LU2468319806.SGD","BK4533","JDOC","LU1236620750.USD","LU2089984988.USD","IE00BVYPNV92.GBP","BK4550","LU2433249047.HKD","LU0122379950.USD","LU0203345920.USD","XLV","FTXH","LU0320765646.SGD","BK4534","LU0289739699.SGD","IE0009355771.USD","PJP","LU0726765562.USD","GLAM","LU0310799852.SGD","IE00B3PB1722.GBP","VHT","LU1720051017.SGD","AGNG","TRUH","IYH","LU1839511570.USD","LU2357627491.SGD","MEDX","FHLC","LU0029864427.USD","IXJ","LU0795875086.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673103450","title":"Genmab at 3-Year High After Blood Cancer Drug Combination Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2673103450","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673103450?lang=en_us&edition=fundamental","pubTime":"2026-10-06 15:18","pubTimestamp":1791271123,"startTime":"0","endTime":"0","summary":"BUZZ-Genmab at 3-year high after blood cancer drug combination study results** Shares in GenmabGMAB.COrise around 8%to their highest in three years, hitting top of STOXX 600.STOXXindex** Genmab and Ab","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL8N45S0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443622.USD","LU2129689514.USD","IE00BSNM7G36.USD","LU0942090050.USD","LU1929549753.HKD","JDOC","LU1037948541.HKD","LU1732799900.SGD","LU1989772923.USD","LU0456855351.SGD","ABBV","LU2357305700.SGD","IXJ","LU0708994859.HKD","IE00BDGV0183.EUR","VHT","XLV","FHLC","LU1732800096.USD","LU0203345920.USD","BK4139","LU1934455863.HKD","LU0859254822.USD","LU0912757837.SGD","IE000MB6IJN5.SGD","IE00B42XCP33.USD","MEDX","IE00B19Z3581.USD","PJP","LU0417517546.SGD","LU0868494617.USD","FTXH","LU0472753341.HKD","LU0965509010.AUD","SG9999003800.SGD","BK4550","LU0882574055.USD","SG9999001440.SGD","TRUH","LU1244550494.USD","LU0256863811.USD","RXL","LU0795875086.SGD","AGNG","LU1003077747.HKD","PPH","GLAM","IYH","LU0211328371.USD","IE0000B7K699.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673082351","title":"Align Technology Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673082351","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673082351?lang=en_us&edition=fundamental","pubTime":"2026-10-06 05:17","pubTimestamp":1791235020,"startTime":"0","endTime":"0","summary":"DJ Align Technology Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Align Technology Inc.  shed 2.15% to $140.65 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.This was the stock's third consecutive day of losses.Align Technology Inc. closed 29.83% below its 52-week high of $200.44, which the company achieved on April 21st.The stock underperformed when compared to some of its competitors Monday, as Zimmer Biomet Holdings Inc.  rose 3.72% to $91.57 and Dentsply Sirona Inc.  fell 1.27% to $8.56.Trading volume  eclipsed its 50-day average volume of 909,671.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930813.SGD","LU0130517989.USD","LU2023250504.SGD","LU0128525929.USD","GLAM","LU0477156953.USD","LU2023250843.SGD","LU1267930490.SGD","LU0130102774.USD","LU1917777945.USD","XRAY","ZBH","LU1267930573.SGD","BK4534","LU1974910355.USD","BK4588","ALGN","LU0889566641.SGD","BK4504","LU0648001328.SGD","IE00B19Z3B42.SGD","LU1201861249.SGD","LU0310800379.SGD","LU0980610538.SGD","BK4198","BK4566","BK4082","IE0002270589.USD","LU0310799852.SGD","LU0211328371.USD","LU0708994859.HKD","LU0211327993.USD","LU0792757196.USD","LU2106854487.HKD","LU0006061336.USD","IE00B19Z3581.USD","BK4585","IE00B7SZLL34.SGD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084323","title":"AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084323","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084323?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:31","pubTimestamp":1791232260,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  advanced 1.12% to $265.76 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.This was the stock's second consecutive day of gains.AbbVie Inc. closed 1.35% short of its 52-week high of $269.39, which the company achieved on September 23rd.The stock outperformed some of its competitors Monday, as Johnson & Johnson  fell 1.21% to $252.93, Pfizer Inc.  fell 1.40% to $27.41, and Amgen Inc.  fell 0.01% to $402.98.Trading volume  eclipsed its 50-day average volume of 4.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","VHT","LU0114720955.EUR","LU0124676726.USD","LU1934455194.USD","IE0000B7K699.USD","SG9999001440.SGD","LU0726765562.USD","LU1093756168.USD","LU0289739343.SGD","XLV","LU0211328371.USD","LU1496350171.SGD","LU2347655073.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","RXL","IE00BN8TJ469.HKD","LU0058720904.USD","LU2237443622.USD","LU0170899867.USD","LU1061106388.HKD","LU1732799900.SGD","LU1244550494.USD","LU1732800096.USD","LU1551013342.USD","IE00BVYPNV92.GBP","LU2237443465.HKD","LU2433249047.HKD","LU1162221912.USD","LU1934455277.USD","IE00BSNM7G36.USD","IYH","LU0553294199.USD","BK4588","LU1929549753.HKD","LU0289739699.SGD","LU2357627491.SGD","LU2125909247.SGD","LU2347655156.SGD","LU0738911758.USD","LU0965509010.AUD","IXJ","SG9999015978.USD","LU0256863902.USD","IE0004445239.USD","IE00BBT3K403.USD","IE00B4R5TH58.HKD","IE00B19Z3581.USD","LU0203347892.USD","LU2089283258.USD","LU0432979614.USD","FHLC","LU0943347566.SGD","LU0859254822.USD","LU1074936037.SGD","LU0912757837.SGD","IE000F7OJYX1.SGD","LU1670628061.USD","LU1236620834.HKD","LU0057025933.USD","LU2089284900.SGD","LU0795875169.SGD","IE00BJJMRZ35.SGD","LU0029864427.USD","LU0882574055.USD","LU0234570918.USD","LU0310800379.SGD","LU1037948541.HKD","LU1057294990.SGD","LU1551013425.SGD","IE000WAW04H5.SGD","LU0456855351.SGD","LU1989772840.SGD","LU2089984988.USD","SG9999015986.USD","LU0069063385.USD","LU1934455863.HKD","LU0985320562.USD","SG9999011175.SGD","LU0310799852.SGD","TRUH","LU1670627923.USD","BK4585","LU0868494617.USD","LU1430594728.SGD","LU2087621335.USD","LU1585245621.USD","LU1923622614.USD","LU1003077747.HKD","LU0289961442.SGD","LU1023059063.AUD","LU0965509101.SGD","LU0203345920.USD","SG9999015945.SGD","BK4550","IE00B42XCP33.USD","AGNG","ABBV","GLAM","LU0417517546.SGD","LU1989772923.USD","BK4534","LU1236620750.USD","LU0965509283.SGD","LU0708994859.HKD","LU0965508806.USD","LU2125909593.SGD","IE000BZT7R73.USD","LU0098860793.USD","LU0158827948.USD","LU1291159041.SGD","IE0009355771.USD","LU2023251221.USD","LU1244550577.SGD","LU0795875086.SGD","LU0395794307.EUR","LU1983299246.USD","LU2129689514.USD","MEDX","LU2357305700.SGD","PJP","LU0689626769.HKD","IE00B3PB1722.GBP","IE00BLSP4452.SGD","IE00BVYPNW00.USD","LU2237443549.SGD","LU0823416689.USD","LU0198837287.USD","LU1989771016.USD","LU0472753341.HKD","IE000SO60NU8.SGD","IE00BGHQF631.EUR","LU0128525929.USD","LU0942090050.USD","LU0868494708.USD","LU2468319806.SGD","LU0320765646.SGD","LU1496350502.SGD","LU1718418525.SGD","LU2112291526.USD","LU2129689605.HKD","LU0256863811.USD","LU2237443895.HKD","BK4566","BK4139","LU0949170772.SGD","LU2129689431.USD","LU0820561818.USD","BK4581","LU0861579265.USD","LU1548497426.USD","LU1267930573.SGD","IE00B2B36J28.USD","LU0211327993.USD","LU1720051108.HKD","IE00BJT1NW94.SGD","IE000MB6IJN5.SGD","LU1244550221.USD","LU2237443978.SGD","IE00BDGV0183.EUR","IE0002141913.USD","LU0122379950.USD","LU2133065610.SGD","BK4533","LU1839511570.USD","LU0661504455.SGD","IE0002270589.USD","IE00BLSP4239.USD","LU0511384066.AUD","LU1267930490.SGD","LU0234572021.USD","LU1720051017.SGD","SG9999015952.SGD","BK4559","IE00BFTCPJ56.SGD","JDOC","LU0545039389.USD","LU0820561909.HKD","PPH","FTXH","LU1093756325.SGD","LU1037948897.HKD","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}